Cormorant Asset Management, LP - Insider Trading & Ownership
-
Entity
-
Company
-
Location
-
200 Clarendon Street, 52 Nd Floor, Boston, MA
-
Summary
-
The estimated value of insider holdings of Cormorant Asset Management, LP is at least $1.05B dollars as of November 6, 2024. Cormorant Asset Management, LP is the 10%+ Owner of Ambrx Biopharma Inc. and owns shares of Ambrx Biopharma Cayman, Inc. stock worth about $642M. Cormorant Asset Management, LP is the 10%+ Owner of Ambrx Biopharma, Inc. and owns shares of Ambrx Biopharma, Inc. stock worth about $110M. Cormorant Asset Management, LP is the 10%+ Owner of EyePoint Pharmaceuticals, Inc. and owns shares of EyePoint Pharmaceuticals, Inc. (EYPT) stock worth about $103M. Cormorant Asset Management, LP is the Former 10% Owner of Monte Rosa Therapeutics, Inc. and owns shares of Monte Rosa Therapeutics, Inc. (GLUE) stock worth about $60.8M. Cormorant Asset Management, LP is the 10%+ Owner of Corbus Pharmaceuticals Holdings, Inc. and owns shares of Corbus Pharmaceuticals Holdings, Inc. (CRBP) stock worth about $52.8M. Cormorant Asset Management, LP is the Former 10% Owner of Aerovate Therapeutics, Inc. and owns shares of Aerovate Therapeutics, Inc. (AVTE) stock worth about $39.6M. Cormorant Asset Management, LP is the Former 10% Owner of Verve Therapeutics, Inc. and owns shares of Verve Therapeutics, Inc. (VERV) stock worth about $9.84M. Cormorant Asset Management, LP is the 10%+ Owner of Immuneering Corp and owns shares of Immuneering Corp (IMRX) stock worth about $8.6M. Cormorant Asset Management, LP is the Former 10% Owner of Tyra Biosciences, Inc. and owns shares of Tyra Biosciences, Inc. (TYRA) stock worth about $7.04M. Cormorant Asset Management, LP is the Former 10% Owner of Icosavax, Inc. and owns shares of Icosavax, Inc. stock worth about $6.68M. Cormorant Asset Management, LP is the Former 10% Owner of Ventyx Biosciences, Inc. and owns shares of Ventyx Biosciences, Inc. (VTYX) stock worth about $2.99M. Cormorant Asset Management, LP is the Former 10% Owner of Vigil Neuroscience, Inc. and owns shares of Vigil Neuroscience, Inc. (VIGL) stock worth about $2.31M. Cormorant Asset Management, LP is the Former 10% Owner of Pyxis Oncology, Inc. and owns shares of Pyxis Oncology, Inc. (PYXS) stock worth about $1.57M. Cormorant Asset Management, LP is the Former 10% Owner of Elevation Oncology, Inc. and owns shares of Elevation Oncology, Inc. (ELEV) stock worth about $1.14M.